Sex-specific effects of N-acetylcysteine in neonatal rats treated with hypothermia after severe hypoxia-ischemia  by Nie, Xingju et al.
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a  b  s  t  r  a  c  t
Approximately  half of  moderate  to severely  hypoxic-ischemic  (HI)  newborns  do not respond  to  hypother-
mia,  the  only  proven  neuroprotective  treatment.  N-acetylcysteine  (NAC),  an  antioxidant  and  glutathione
precursor,  shows  promise  for  neuroprotection  in  combination  with  hypothermia,  mitigating  post-HI  neu-
roinﬂammation  due  to  oxidative  stress.  As  mechanisms  of HI  injury  and  cell death  differ  in males  and
females,  sex  differences  must  be  considered  in  translational  research  of  neuroprotection.  We  assessed
the  potential  toxicity  and  efﬁcacy  of  NAC  in  combination  with  hypothermia,  in male  and female  neonatal
rats  after  severe  HI injury.  NAC  50 mg/kg/d  administered  1  h  after  initiation  of  hypothermia  signiﬁcantly
decreased  iNOS  expression  and  caspase  3 activation  in  the  injured  hemisphere  versus  hypothermia  alone.
However,  only  females  treated  with  hypothermia  +NAC  50 mg/kg  showed  improvement  in short-termex
europrotection
edox regulation
infarct  volumes  compared  with  saline  treated  animals.  Hypothermia  alone  had no  effect  in this  severe
model.  When  NAC  was  continued  for 6  weeks,  signiﬁcant  improvement  in  long-term  neuromotor  out-
comes  over  hypothermia  treatment  alone  was  observed,  controlling  for  sex.  Antioxidants  may  provide
insufﬁcient  neuroprotection  after  HI for neonatal  males  in the short  term,  while  long-term  therapy  may
beneﬁt  both  sexes.
rs.  Pu©  2016  The  Autho
. IntroductionHypothermia treatment for hypoxic-ischemic (HI) neonates
ecreases the incidence of severe neurodevelopmental outcomes at
Abbreviations: CXCL-1/GRO, chemokine C-X-C ligand 1/growth-regulated
ncogene alpha; CXCL-2/GRO, chemokine C-X-C ligand 2/macrophage inﬂamma-
ory protein 2-alpha/growth-regulated protein beta; HI, hypoxia ischemia; HNAC,
ypothermia with N-acetylcysteine treatment; HYPO, hypothermia treatment;
CAM, intercellular adhesion molecule; IL, interleukin; iNOS, nNOS, inducible or
euronal nitric oxide synthase; MBP, myelin basic protein; MMP, matrix metal-
oproteinase; NAC, N-acetylcysteine; NO, nitric oxide; PND, postnatal day; TTC,
,3,5-Triphenyl-tetrazolium chloride; VEH, vehicle, saline treatment.
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12–24 months of age to approximately 45–55%, without apparent
differences in efﬁcacy between sexes (Eicher et al., 2005; Shankaran
et al., 2008; Azzopardi et al., 2009; Simbruner et al., 2010). With
hypothermia now recognized as the clinical standard of care, the
addition of other neuroprotective agents to hypothermia treat-
ment are being investigated to improve outcomes further (Barks
et al., 2010; Liu et al., 2012; Hobbs et al., 2008; Fan et al., 2013).
N-acetylcysteine (NAC) is a promising antioxidant therapy that
impacts many pathways of injury and has established neuroprotec-
tive effects in animal models of HI and neuroinﬂammation (Jatana
et al., 2006; Paintlia et al., 2004; Liu et al., 2010). Immune and
inﬂammatory responses to HI are modulated by cellular redox sta-
tus, and increased apoptotic signaling pathways are present in cells
with low anti-oxidant reserves (Lu, 2009; Cook et al., 2004; Circu
and Aw, 2010; Wang and Kaufman, 2012; Ten and Starkov, 2012;
Jager et al., 2012).
In our previous work, hypothermia plus NAC 50 mg/kg/day
improved infarct volumes and negative geotaxis performance
in neonatal animals subjected to right common carotid artery
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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igation and 2 h of hypoxia, although sex effects were not eval-
ated (Jatana et al., 2006). For translation to therapeutic trials,
hese ﬁndings need to be replicated with robust statistical power,
nd optimal timing and dosing regimens determined. Furthermore,
ncreasing evidence from in vitro and in vivo studies point to dif-
erent mechanisms of injury, cell death, neuroinﬂammation and
ossibly repair between males and females in neonatal animals,
ven though both sexes are exposed to signiﬁcant maternal estro-
en (Zhang et al., 2010; Offner et al., 2009; Liesz et al., 2009; Nijboer
t al., 2007; Zhu et al., 2006; Wen  et al., 2006; Park et al., 2006; Weis
t al., 2012). These different injury mechanisms warrant analyti-
al consideration of sex-speciﬁc treatment effects. We  performed
 experiments with NAC plus hypothermia to determine sex differ-
nces in mechanisms of neuroprotection, to choose dose and timing
f NAC administration, and to determine long-term outcomes in a
evere HI model.
. Materials and methods
.1. Animal
Postnatal day (PND) 7 Sprague-Dawley rats were used for all
xperiments (Harlan, Indianapolis, IN). Animals were housed in
he animal care facility of the Medical University of South Carolina
MUSC) with a 12/12 h light/dark cycle, and given standard chow
nd water ad libitum. All procedures were in accordance with the
uide for the Care and Use of Laboratory Animals adopted by the
ational Institutes of Health and approved by the MUSC Animal
are and Use Committee.
.2. Reagents
2,3,5-Triphenyl-tetrazolium chloride (TTC) and paraformalde-
yde (Sigma Chemical Co., St. Louis, MO); NovaplusTM (Isoﬂurane,
SP) (Abbot Laboratories, North Chicago, IL); VECTASHIELD Hard
etTM Mounting Medium with DAPI (H-1500, Vector Laborato-
ies, Burlingame, CA); anti-Activated Caspase 3 (Abcam, Cambridge,
A); N-acetylcysteine (Acetadote, Cumberland Pharmaceuticals,
ashville, TN).
.3. Hypoxia-ischemia animal model
PND 7 rat pups were randomized to experimental groups within
itters. Liters were limited to 10 pups to ensure equal maternal
ccess. We  used the modiﬁed Levine model of HI injury with unilat-
ral ligation of the right common carotid artery and 2 h exposure to
% oxygen atmosphere for all experiments as previously described
Jatana et al., 2006; Geddes et al., 2001). At the end of hypoxia,
ups were exposed to systemic hypothermia (30 ± 0.5 ◦C) or nor-
othermia (36.3 ± 0.5 ◦C) in temperature controlled chambers for h (Jatana et al., 2006). Rectal temperatures were in the target
ange of 33.5–34.5 ◦C for the hypothermic rats, and 36.5–37.5 ◦C
or the normothermic group, similar to that used in clinical trials
f therapeutic hypothermia. Sham operated animals underwentrimental design.
anesthesia and a neck incision without ligation or hypoxia and
received normothermia and intraperitoneal saline. All treatment
groups were administered NAC or vehicle (saline) intraperitoneal
1 h after hypoxia (1 h after initiation of hypothermia). Animals
were removed from respective temperature chambers brieﬂy for
the injection and replaced. NAC or saline injections were repeated
daily until sacriﬁce: Sham, Vehicle (VEH) and hypothermia alone
(HYPO) groups received saline; Hypothermic NAC rats received 50
or 150 mg/kg/day of NAC (HNAC 50, HNAC 150). Control groups
were limited to sham surgery, untreated HI injury (VEH), and
the clinical standard of care hypothermia after HI (HYPO), as
prospective therapies would be used only in addition to hypother-
mia  clinically. Daily weights were recorded from PND 7 until
sacriﬁce.
2.4. Experimental design
Experiment 1: For caspase 3 activation by parafﬁn-embedded
immunohistochemistry, 31 rats were randomized to Sham (n = 2),
VEH (n = 8), HYPO (n = 8), HNAC 50 (n = 7), HNAC 150 (n = 4 survived,
n = 2 expired) with sacriﬁce at 24 h. For cytokine and inﬂamma-
tory mediator expression by quantitative RT-PCR in ﬂash frozen
brain tissue, an additional 44 rats were randomized to the 5 groups
(4–5 rats per sex per treatment) with sacriﬁce at 24 h. Experiment
2: PND 7 rats (n = 184) were randomized into 9 groups to evalu-
ate for timing of NAC administration based on hours after onset
of hypothermia: Sham (n = 12), VEH (n = 20), HYPO (n = 28), HNAC
50 1 h (n = 20), HNAC 50 3 h (n = 21), HNAC 50 5 h (n = 20), HNAC
150 (n = 21), HNAC 150 3 h (n = 21), and HNAC 150 5 h (n = 21)
for 48 h infarct volumes. Infarct volumes were measured at 48 h,
comparing volumes within NAC doses of 50 and 150 mg/kg/d, to
select the most effective timing for each dose for further study,
considering possible sex effects. Experiment 3: PND 7 rats were
randomized to Sham, VEH, HYPO, HNAC 50 1 h, HNAC 150 1 h,
HNAC 150 3 h (n = 33, 5–8 rats per treatment group), and saline or
NAC were administered once daily for 6 weeks. Mortality, physical
characteristics, neurological reﬂexes, and strength and coordina-
tion testing were measured until sacriﬁce at 6 weeks after HI
(Fig. 1).
2.5. Randomization, power analyses and outcome measures
Each litter was randomized to include pups of each sex and
treatment group. For Experiment 1, a minimum of n = 4 per sex
to observe a 50% difference by Wilcoxon signed rank test (80%
power, a = 0.05) was  based on previous work looking at iNOS mRNA
levels after HI (Park et al., 2006). For Experiment 2, effect sizes
for differences in infarct volume stratiﬁed by sex were estimated
from a report by Bona et al. (1998), which reported differential
sex effects of hypothermia and 50% reduction in gross morphol-
ogy score in female PND 7 HI rats. For median infarct volumes by
sex with 50% effect size by Wilcoxon signed rank test (80% power,
a = 0.05), a required sample size of 18 rats per treatment group, (9
per sex). This number was veriﬁed by an independent investigator
2 ce Research 108 (2016) 24–33
(
i
b
b
d
t
2
i
i
p
1
m
h
c
t
s
(
2
c
i
Q
B
5
I
P
P
w
9
f
p
s
f
u
2
a
2
t
t
t
w
w
2
t
m
a
d
l
g
i
d
2
s
Fig. 2. Activated caspase 3+ cells in ipsilateral cortex harvested 24 h after HI injury.
(A)  Representative cortical sections showing caspase 3+ (green) and DAPI (blue)
labeled cells. (B) Median and IQR of the percent of total cells that were activated
caspase 3+, of three HPFs in ipsilateral cortex at 24 h after HI. There are signiﬁcantly
fewer caspase 3+ cells in the cortex of HNAC 50 1 h and HNAC 150 1 h rats com-
pared with HYPO animals (*p < 0.04). Sham (n = 2), VEH (n = 8), HYPO (n = 8), HNAC 506 X. Nie et al. / Neuroscien
Silverstein, personal communication) based on the variability of
njury observed in this animal model. For Experiments 2 and 3
ehavioral and sensorimotor function studies, a minimum of n = 5,
alanced by sex, was based on previous behavioral differences
etected at 7 days post injury by our lab by Wilcoxon signed rank
est (80% power, a = 0.05) (Jatana et al., 2006).
.6. Immunohistochemistry (IHC) for activated caspase 3 and
nfarct volume
Parafﬁn-embedded rat brain sections harvested 24 h after HI
njury were prepared for immunohistochemistry, using standard
rotocols with a 1:100 dilution of anti-activated caspase-3 and
:1000 dilution of ﬂuorescent-conjugated secondary antibody, and
ounted with aqueous mounting media containing DAPI. Three
igh power ﬁelds were counted in intact penumbral tissue (parietal
ortex) for caspase-labeled and total cells. Infarct volume was  quan-
iﬁed using 2,3,5-triphenyl-tetrazolium chloride (TTC, in saline)
taining as previously described using Image J analysis software
NIH) (Jatana et al., 2006).
.7. Quantitative real time reverse transcriptase-polymerase
hain reaction (RT-PCR)
Brains were rapidly dissected and snap frozen 24 h after HI
njury. Total RNA was extracted (RNeasy Lipid Tissue Mini Kit,
IAGEN, MD)  and reverse transcribed (iScript cDNA Synthesis Kit,
io-Rad, CA) with cycles of 5 min  at 25 ◦C, 30 min  at 42 ◦C, and
 min  at 85 ◦C. The primer sets for -actin, COX2, CXCL1, CXCL2,
CAM-1, IL-1, IL-4, IL-6, INF-, iNOS, MBP, MMP9, MMP13, nNOS,
PAR, and TNF- are included in Supplemental Table 1. Real-time
CR was conducted using a Bio-Rad iCycler (Bio-Rad, Hercules, CA)
ith the following protocol: activation of iTaq DNA polymerase at
5 ◦C for 10 min, followed by 40 cycles of ampliﬁcation at 95 ◦C
or 30 s and 63 ◦C for 1 min. Gene expression levels in each sam-
le were quantiﬁed against a standard curve, normalized to the
ample -actin units and calculated according to the following
ormula: relative target gene product units = sample target gene
nits/sample -actin units.
.8. Early neurobehavioral reﬂexes
Negative Geotaxis tests the righting reﬂex after being placed in
 head down position on a board positioned at 45◦. In Experiment
, rat pups had 20 s to turn >90◦ toward the top of the board, or
he maximum time was assigned. A more difﬁcult version of the
est was utilized in Experiment 3 with animals having to climb up
he board with both forelimbs reaching the top edge of the board
ithin a time limit of 30 s. Day of appearance was the ﬁrst day in
hich the rat reached the top under 30 s.
.9. Physical characteristics, reﬂexes, coordination and strength
esting
In Experiment 3, Protocols for testing the long term develop-
ent of strength, coordination and physical reﬂexes were followed
s previously described (Lubics et al., 2005): Weights were recorded
aily from PND 7-21 then twice weekly from PND 22-49. Neuro-
ogical reﬂexes (eye twitch, ear twitch, righting reﬂex, limb placing,
rasp, gait, cliff aversion, negative geotaxis) and physical character-
stics (eye opening, ear unfolding, incisor eruption) were recorded
aily from PND 8-21..9.1. Rope suspension test
To measure forearm strength in the affected limb, rats were
uspended by both forelimbs (two arm suspension) and only the(n  = 7), HNAC 150 (n = 4 survived, n = 2 expired), Kruskal–Wallis with Mann–Whitney
post hoc.
affected forelimb (one arm suspension) on a 1/6′′ diameter nylon
rope above a foam pad. The duration of suspension was recorded. If
the rat held on for entire 30 s, or pulled itself to the end of the rope
and climbed onto the post, a time of 30 s was recorded. After testing
two-arm suspension, rats had a 10 min  rest before the unaffected
limb was  immobilized with tape, and one arm suspension was
assessed. The test was  performed twice weekly from PND 14–49.
2.9.2. Grid walking
To analyze hindlimb placing deﬁcits, rats were placed on a
32 cm × 40 cm grid with a mesh size of 4 cm2, raised 12 inches above
the benchtop, and observed for 1 min. The total number of steps
and the number of times a limb fell though the mesh opening (foot
faults) were recorded.
X. Nie et al. / Neuroscience Research 108 (2016) 24–33 27
Fig. 3. PCR analysis of inﬂammatory mediators at 24 h, normalized to -actin. Median and 95% CI by treatment (A) and by sex (B–D). Irrespective of sex (A), HNAC 50 1 h
was  signiﬁcantly different than HYPO (*p < 0.037) for both iNOS and nNOS. (B) iNOS expression: Male Veh animals had signiﬁcantly higher iNOS expression than HNAC 50
males, and tended to have higher iNOS than females Veh animals (p = 0.057). HNAC treatment tended to reduce iNOS vs. HYPO (p = 0.063) in females. Hypothermia alone had
no  signiﬁcant effect on iNOS expression in this severe model. (C) nNOS expression: Within the VEH group, nNOS expression was signiﬁcantly higher in females than males.
Within females, HNAC 50 1 h nNOS expression was signiﬁcantly higher than HYPO. (D) MBP  expression: Within the VEH group, MBP  expression was  signiﬁcantly higher in
females than males. In HYPO females MBP  expression was lower compared to VEH females. Within the HNAC 50 or 150 1 h groups, males and females were not signiﬁcantly
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tifferent in expression of iNOS, nNOS, or MBP. n = 4–5 rats per sex per treatment, K
.10. Statistical analysis
For infarct volumes and gene expression, non-parametric
ruskal–Wallis tests were used to determine differences between
roups with Mann–Whitney post hoc testing. Changes in daily
easures of physical characteristics, reﬂexes, negative geotaxis,
ighting reﬂex, gait, weight, rope suspension, and grid walking
ere analyzed over time using Univariate and General Linear
ixed Regression models for repeated measures with Tukey’s post
oc analysis. Negative geotaxis and gait were analyzed by abso-
ute time and the ﬁrst day the rat achieved a recorded time of
29 s (Day of Appearance). Righting reﬂex was  analyzed by abso-
ute time and the day on which the rat righted within 1 s (Day
f Appearance). For rope suspension data, square root transfor-
ation preceded mixed model analysis with repeated measures.
or Experiment 2, the decision was made a priori to compare
he 3 control groups with the earliest NAC dosing, and then to–Wallis with Mann–Whitney post hoc.
examine timing of the two NAC does separately. For Experiment
3, comparisons were made within control (Sham, VEH and HYPO)
and hypothermia treatment groups (HYPO, HNAC dosing groups),
since hypothermia is the clinical standard of care. Signiﬁcance was
deﬁned as p < 0.05. All statistical calculations were done with SPSS
version 20.0.
3. Results
3.1. Experiment 1: HNAC treatment shows sex differences in
inﬂammatory mediator expression
3.1.1. HNAC 1 h decreased cell death at 24 h
Brain sections stained for activated caspase 3 displayed signif-
icantly fewer apoptotic cells in the penumbra of the ipsilateral
cortex at 24 h after HI injury in the HNAC animals compared with
HYPO rats (n = 4–8/group, Fig. 2A, B). Despite having two HNAC
28 X. Nie et al. / Neuroscience Research 108 (2016) 24–33
Fig. 4. PCR analysis of inﬂammatory mediators at 24 h by sex, normalized to -actin. Box plot within sex, male treatment groups are represented in gray, females in white.
Within the HYPO group, ICAM1 (A), MMP  9 (B), and CXCL1 (C) levels were signiﬁcantly higher in females compared to males, with strong trends for CXCL2 (D) and IL6 (E)
(p  = 0.057). With addition of NAC 50 1 h to hypothermia, the increased expression of ICAM, MMP-9, CXCL1, CXCL2 in female HYPO rats was  abolished, and expression in HNAC
f  per se
1
t
g
H
a
a
w
i
2
3
i
s
S
l
s
H
V
a
e
r
r
a
2emales  was similar to that in males for these inﬂammatory mediators. n = 4–5 rats
50 1 h animals die, there was no increased cell death observed in
he remaining HNAC 150 animals. As females are reported to have
reater caspase-mediated apoptosis than male rats after moderate
I (Mirza et al., 2015), we explored differences between females
nd males within treatment groups in our severe HI model. Males
nd females had similar caspase 3 activation in the penumbra
ithin all groups (n = 2–4 per sex, per group, data not shown), sim-
lar to ﬁndings by other investigators in severe HI (Askalan et al.,
015).
.1.2. HNAC decreases iNOS expression in ipsilateral hemisphere
n both sexes
Expression of inﬂammatory mediators in the ipsilateral hemi-
phere were analyzed at 24 h after HI (n = 8–10/group, Fig. 3A and
upplemental Fig. 1). HNAC 50 treatment resulted in signiﬁcantly
ower iNOS expression than HYPO alone in the combined sex analy-
is (p = 0.009), while nNOS expression was signiﬁcantly higher with
NAC 50 than HYPO alone (p = 0.037).
Our data show sex differences in nNOS and MBP expression.
EH HI females have higher nNOS and MPB  expression than males
nd tend toward lower iNOS, as shown by other investigators (Park
t al., 2006; Bonnin et al., 2012; McCullough et al., 2005). Previous
eports also show nNOS is neuroprotective in female, but not male
ats (McCullough et al., 2005), while male rats have greater neural
nd white matter injury after HI (Nijboer et al., 2007; Zhu et al.,
006; Bona et al., 1998; Park et al., 2006; Weis et al., 2012) Nox per treatment, Kruskal–Wallis with Mann–Whitney post hoc.
gender differences in NOS or MBP  expression were observed after
hypothermia or HNAC treatment (Fig. 3B, C).
3.1.3. Sex differences in inﬂammatory mediator expression were
present within hypothermia treated animals but not within HNAC
animals
Analyses of inﬂammatory mediators demonstrated expres-
sion differences based on sex in endothelial activation (ICAM,
MMP9) and neutrophil chemotactic (CXCL1/CXCL2, IL-6) factors
(p < 0.05). Male HYPO rats showed signiﬁcantly lower expres-
sion of MMP9, ICAM, and CXCL1, compared with female HYPO
rats (Fig. 4A–C). Male HYPO rats also showed a trend toward
lower expression of chemotactic proteins CXCL2/GRO (mono-
cytes) and IL-6 (neutrophils) than HYPO females (Fig. 4D, E).
However, when NAC was added to hypothermia, levels of ICAM
and MMP9  (Fig. 4A, B) and CXCL1/GRO expression (Fig. 4C)
decreased in females to near male levels. Taken together, these
ﬁndings suggest that hypothermia regulates transcription of these
mediators of endothelial activation and immune response dif-
ferentially in males and females. However, the addition of NAC
modulates markers of endothelial-immune activation observed in
hypothermia treated female rats. MMP13, COX2, IFN-g, TNF-a, and
IL-4 were not different among treatment groups (Supplemental
Fig. 1).
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Fig. 5. Infarct volumes at 48 h. Median values are marked by bar. For the over-
all infarct volume (A), there was a trend toward a treatment effect (p = 0.0792),
with HNAC 50 1 h having the lowest median infarct volumes. In the female rats (B),
treatment had a signiﬁcant effect on infarct volumes (p = 0.0198): HNAC 50 mg/kg/d
provided signiﬁcant neuroprotection and HYPO had marginal neuroprotection vs.
VEH (p = 0.059). HNAC 150 mg/kg/d exhibited increased median infarct volume com-
pared to HYPO or HNAC 50, similar to VEH. No treatment effect was observed inX. Nie et al. / Neuroscien
.2. Experiment 2: Infarct volume and negative geotaxis improve
ith NAC 50 treatment when started during hypothermia in
emales
.2.1. NAC 50 1 h decreased infarct volumes in female neonatal
ats when given during hypothermia
The combined sex analysis of infarct volumes at 48 h did not
how deﬁnitive neuroprotective effect of NAC 50 mg/kg/d admin-
stered 1 h after the start of hypothermia (n = 20–28, p = 0.079;
ig. 5A). In females, there were signiﬁcant differences in infarct
olumes between treatments (p = 0.0198, Fig. 5B). HNAC 50 pro-
ided signiﬁcant neuroprotection, and HYPO showed a strong trend
oward neuroprotection, compared to VEH female animals in this
evere model. However, median infarct volumes in female animals
iven HNAC 150 were signiﬁcantly increased compared to HNAC
0 or HYPO females, and equal to VEH. Male rats exhibited no
mprovement with either NAC dose over hypothermia alone in
8 h infarct volumes (Fig. 5C). For neurobehavioral reﬂex testing,
here were no overall treatment differences in negative geotaxis
t 48 h after HI injury in the combined gender analysis. How-
ver, among female rats, both HNAC 1 h treated groups performed
igniﬁcantly better than HYPO alone in the time to rotate >90◦
p < 0.036), but were not signiﬁcantly different than VEH (Supple-
ental Fig. 2). Taken together, results from Experiments 1 and 2
how that low dose NAC in combination with hypothermia improve
ediators of inﬂammation after severe HI in the ﬁrst 24 h after
I injury. In addition, the data show smaller infarct volumes at
8 h in female HI rats exposed to hypothermia and NAC com-
ared to vehicle animals, while hypothermia alone provided no
europrotection.
.2.2. Delay of high dose NAC administration improves infarct
olumes
To determine the effects of delaying NAC treatment after
ypothermia, we compared 1, 3, and 5 h NAC dosing (50 and
50 mg/kg) after the initiation of hypothermia treatment. Among
NAC 50 groups, longer delays in administration did not improve
nfarct volumes at 48 h (Fig. 6A). Using higher dose NAC, infarct
olume decreased with NAC administration 3 and 5 h after
ypothermia (Fig. 6B), compared with toxicity of this dose when
iven during hypothermia. There were no sex differences within
he 3 and 5 h groups for either NAC dose.
.3. Experiment 3: Long-term sensorimotor function improves
ith HNAC 50 mg/kg/day for 6 weeks
.3.1. Long-term treatment with NAC 50 mg/kg was well tolerated
Based on the results of Experiment 2, HNAC 50 1 h, HNAC 150
 h, and HNAC 150 3 h q24h for 6 weeks (n = 5–8) were selected to
valuate long-term behavioral outcomes and toxicity. Weight was
easured twice weekly, as failure to gain weight is a measure of
oxicity. HNAC 50 rats had consistent weight gain throughout the
tudy, similar to sham. However, HNAC 150 1 h rats demonstrated
ecreased rate of weight gain, starting 24d after injury (data not
hown). Three pups in the HNAC 150 1 h and 1 pup in the HNAC 150
 h treatment groups lost weight and exhibited decreased activity
rior to demise during weeks 5–6, and were excluded from those
nalyses. There were no differences in development of physical
haracteristics among hypothermia groups.
.3.2. HNAC 50 improves long-term neuromotor tests, controlling
or sexConsistent with infarct volume results in this moderate to severe
odel, hypothermia treatment did not improve performance over
EH rats, with the exception of the grid-walking test (Fig. 7A, D,
, J). These neurobehavioral outcomes deﬁne the time course ofmales (C, p = 0.5947). Sham (n = 12), VEH (n = 20), HYPO (n = 28), HNAC 50 1 h (n = 20),
HNAC 150 (n = 21), Kruskal–Wallis with Mann–Whitney post hoc.
long-term functional deﬁcits in this severe HI model, and these
results are comparable to published data (Lubics et al., 2005; Bona
et al., 1998; Fan et al., 2013). On strength testing by rope suspension
over the 35 days of testing, HNAC 50 1 h group displayed the best
performance in both two-arm (Fig. 7B) and one-arm tests (Fig. 7E).
In the two-arm suspension test, HNAC 50 1 h and 150 3 h rats tended
to hold on longer than hypothermia alone early after injury (Fig. 7B,
C). However, in the more difﬁcult one arm test, signiﬁcant improve-
ment in HNAC 50 1 h rats performance compared with HYPO rats
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Fig. 6. Infarct volumes at 48 h with delayed initiation of therapy. Median values (irrespective of sex) are marked by bar, HYPO group included for reference. With the HNAC
50  dose (A), there was  no signiﬁcant difference with delayed dose administration. However in the HNAC 150 dose (B), the infarct size signiﬁcantly improved with delayed
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as detectable as early as day 17 (p = 0.014) and persisted into 6th
eek after HI injury (Fig. 7F).
For negative geotaxis (Fig. 7H, I), HNAC 50 1 h rats ﬁrst com-
leted the task on average 3 days earlier than HYPO rats (Fig. 7I)
nd consistently performed the best of all hypothermia groups
hroughout testing (Fig. 7H). In an ambulatory test of locomotion
nd accuracy of hind limb placing (grid walking), HNAC 50 1 h rats
ook signiﬁcantly more total steps from days 14 to 38 compared
o HYPO and HNAC 150 1 h rats (Fig. 7L). HNAC 50 1 h rats had
he highest number of total steps, and HNAC 150 1 h the lowest.
here were no additional improvements over hypothermia in grid
alking foot-faults with any NAC dose (Fig. 7K).
. Discussion
Oxidative stress is a major determinant of injury in HI and
eads to accumulation of reactive oxygen species and dysregulated
nﬂammatory cascades (Naik and Dixit, 2011). At the same time,
he neonatal brain handles oxidative stress poorly, with antioxi-
ant activities that are only half of adult levels at term gestational
ge (Aspberg and Tottmar, 1992; Sheldon et al., 2004). Glutathione,
s the major intracellular antioxidant, is an in vivo CNS marker of
he severity of oxidative stress (Satoh and Yoshioka, 2006). Glu-
athione is depleted due to excessive acute or chronic ROS and is
losely associated with neuronal death. (Han et al., 1999; Filibian
t al., 2012; Ceccon et al., 2000) N-acetylcysteine serves as a source
f cysteine, a glutathione precursor, and scavenges oxygen free
adicals with its thiol-reducing group, acting directly and indi-
ectly as a potent antioxidant (Oda et al., 1999; Cuzzocrea et al.,
999; Diniz et al., 2006; Van Antwerpen et al., 2005; Lee et al.,
008a). Importantly, NAC crosses the blood brain barrier, where
t reduces cerebral oxidative stress, preserves peroxisomes and
estores myelination (Farr et al., 2003; Neuwelt et al., 2001; Paintlia
t al., 2004; Lee et al., 2008b). NAC has been shown to improve both
ellular and mitochondrial glutathione redox status and mitochon-
rial membrane potential, which leads to improved cell survival
Okouchi et al., 2009; Wang et al., 2007). These properties make
AC a strong candidate to ameliorate some of the cascades of
nﬂammation and stimulate endogenous repair mechanisms after
I (Paintlia et al., 2004). In our neonatal HI model, neuromotor
ests were improved with long-term, low dose NAC. Hypother-
ia  alone did not demonstrate neuroprotective effects, similar toitney post hoc.
other reports using moderate to severe HI models (Bona et al.,
1998; Burnsed et al., 2015; Traudt et al., 2013; Sabir et al., 2012;
Nedelcu et al., 2000). Our data add to that of other investigations
that have found NAC to be neuroprotective in HI injury and in sev-
eral adult and neonatal animal models of neuroinﬂammation (Lee
et al., 2008b; Cuzzocrea et al., 2000; Wang et al., 2007; Lante et al.,
2008). Thus, NAC in combination with hypothermia may  provide
functional neuroprotection after more severe HI injuries, in which
hypothermia alone is not sufﬁcient to improve outcomes.
Interestingly, in our short-term studies, low-dose NAC added to
hypothermia preserved infarct volumes in female, but not in male,
neonatal rats 48 h after severe HI compared with vehicle controls.
Sex differences in outcomes and injury pathways are increasingly
recognized as important considerations in neuroprotection. We
found sex differences in expression of factors that are secreted
by activated endothelial cells and microglia (Okouchi et al., 2009;
Lijia et al., 2012), and impact neutrophil recruitment (CXCL1/GRO,
CXCL2/GRO) and invasion (ICAM), and tissue integrity (MMP9).
These factors work cooperatively to increase leukocyte-endothelial
interaction and inﬁltration early after HI (Lee and Lo, 2004; Gidday
et al., 2005). Hypothermia down-regulated expression of these
mediators in our male neonatal rats, as has been reported in other
experiments using male animals (Wang et al., 2002; Sarcia et al.,
2003; Bednarek et al., 2012; Liu et al., 2008; Lee et al., 2005). How-
ever, expression of iCAM, MMP9, and CXCL1 were signiﬁcantly
higher in our female hypothermic rats, and only with the addition
of NAC were these mediators decreased to same levels as hypother-
mic  males. Down regulation of MMP9  in particular, is important in
females, since it triggers caspase-mediated apoptosis (the predom-
inant pathway in female neurons), and worsens infarct volumes by
cleaving extracellular matrix components and disrupting homeo-
static integrin signaling (Du et al., 2004; Lee and Lo, 2004). Female
neonatal rats have shown increased cytochrome c-mediated cas-
pase activation and greater mitochondrial loss in the cortex and
hippocampus at 2–18 h after HI compared with males (Weis et al.,
2012; Nijboer et al., 2007).
We  also found overall differences in nNOS and iNOS expression,
with reduced iNOS and restored nNOS expression to near Sham lev-
els with the addition of NAC compared to hypothermia treatment
alone. Indiscriminant iNOS activation under conditions of redox
stress may  result in uncoupling of nitric oxide (NO) production
and electron transfer, leading to peroxynitrite (ONOO−) formation,
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Fig. 7. Functional outcomes at 7 weeks in controls (left panels) and in NAC treatment groups (center and right panels). For control groups, HI injury signiﬁcantly decreased
the  time of rope suspension using two arms (A) and one arm (D) compared to Sham over time (p < 0.00001). Among Hypothermia treatment groups, HNAC 50 and HNAC 150
3  h tended to perform better over other groups between days 24 and 31 using two arms (B, C) although all groups improved over time. In one arm suspension testing (D–F)
using  only affected arm, duration of suspension for HNAC 50 1 h rats were signiﬁcantly better than HYPO as early as Day 17 (p = 0.014), persisting to last week of testing (E).
HNAC 50 1 h rats had the longest times for one-arm rope suspension on day 49 (F) with mean suspension times of 90% of Sham time. In the negative geotaxis testing (G–I),
VEH  and HYPO rats took signiﬁcantly more time to turn around and climb to the top of the board than Sham (G, p = 0.017 and 0.003, respectively). In NAC treatment groups
(H),  HNAC 50 consistently performed better than HYPO (p = 0.018) over time and had earlier successful completion of negative geotaxis (I), with HNAC 50 1 h rats completing
the  task 3 days earlier than HYPO rats. In grid walking (J–L), testing hindimb placing accuracy (foot faults to total steps) from days 14 to 49, HYPO rats were signiﬁcantly
d igniﬁ
t C 50 
1  treatm
o
t
2
r
g
d
t
a
i
lifferent from Sham and VEH groups over time (p < 0.0001), though there was no s
otal  grid walking steps, measuring locomotor activity from days 14 to 38 (H), HNA
50  1 h: 572 steps, HNAC 50 1 h: 617 steps). Error bars indicate ±1 SD. 5–8 rats per
xidation of cysteine residues, and nitration of purines in DNA and
yrosine residues in proteins (Du et al., 2004; McCullough et al.,
005; Hagberg et al., 2004; Chen et al., 2003). In primary neu-
onal cultures exposed to ONOO− for 24 h, XY neurons showed
reater reduction in intracellular glutathione and increased cell
eath compared with XX neurons (Du et al., 2004). Males may,
herefore, be more susceptible to uncoupling of NO production
nd peroxynitrite oxidative stress than females. Under improving
ntracellular redox status, constitutive nNOS and eNOS produce low
evels of endogenous, bioavailable NO, which may  also utilized incant improvement with NAC treatment over hypothermia alone (K). In the sum of
1 h rats took more steps than HYPO (p = 0.043) and HNAC 150 1 h (p = 0.027, HNAC
ent group, mixed regression statistical models.
post-translational modiﬁcation of cell signaling proteins through a
S NO bond (nitrosylation) (Keynes and Garthwaite, 2004; Keynes
et al., 2004; Martinez-Ruiz and Lamas, 2004; Matsumoto et al.,
2003). A key apoptotic mediator, procaspase 3, is maintained in an
inactive state by nitrosylation, while removal of the NO group leads
to caspase 3 activation (Lai et al., 2011). HNAC treatment decreased
iNOS expression and caspase 3 activation, while improving nNOS
expression in both sexes of neonatal rats in our model, indicating
that combined treatment may  beneﬁt some mechanisms of injury
in both sexes.
3 ce Res
o
L
i
i
W
h
i
o
t
T
a
d
w
d
s
h
a
N
a
p
l
m
o
t
e
O
t
n
t
f
i
s
p
N
r
A
a
A
t
0
R
A
A
A
B
B
B2 X. Nie et al. / Neuroscien
Judicious dosing of NAC may  be an important factor in our
bserved functional neuroprotection with longer-term treatment.
ow dose NAC has been shown to attenuate H2O2 production,
nhibit NF-, and decrease ICAM mRNA and protein expression
n oxidatively-stressed endothelial cells (Mukherjee et al., 2007).
hile low dose NAC is beneﬁcial to our hypothermic female HI rats,
igher doses of NAC resulted in signiﬁcantly worse infarct volumes
n our study. High dose NAC is known to increase both reduced and
xidized glutathione, causing reductive stress and unfolded pro-
ein response in the endoplasmic reticulum (Zhang et al., 2012).
he toxicity-related dose effects of NAC also depend on the temper-
ture. At normothermia, 500 mg/kg of NAC was required to cause
etrimental effects in adult HI rats (Khan et al., 2004). However,
ith hypothermia in our study, even the usual clinical anti-oxidant
ose of NAC in acetaminophen overdose (150 mg/kg) in females
howed worsening infarct volumes and increased death. Therefore,
ypothermia seems to lower the threshold for both NAC activity
nd toxicity, possibly through decreased clearance and prolonged
AC half-life.
Improving upon hypothermia’s neuroprotection is challenging,
s it acutely regulates the very cascades affected by other neuro-
rotective agents (Fan et al., 2013; Fang et al., 2013). At the cellular
evel, normalization of cytoplasmic, mitochondrial and endoplas-
ic  reticular oxidative balance is a crucial ﬁrst step for restoration
f homeostasis and growth factor signaling, and is an important
herapeutic target in neurologic diseases (Victor et al., 2003; Jager
t al., 2012; Ten and Starkov, 2012; Lu, 2009; Perrone et al., 2012).
ur data in a severe HI PND7 model show short-term neuropro-
ection only in females treated with NAC plus hypothermia, and
o neuroprotection with hypothermia alone compared with saline
reated animals. Long-term treatment with NAC was required for
unctional improvement in male and female rats after severe HI,
mplying NAC has important effects on repair, neurogenesis, and
ynaptogenesis, which may  be independent of sex. These studies
rovide a basis for further investigations of neuroprotection with
AC, but highlight the importance of sex considerations in neu-
otherapeutics.
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